Barrow, Hanley, Mewhinney & Strauss’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-13,511,900
Closed -$1.28B 418
2018
Q3
$1.28B Sell
13,511,900
-287,674
-2% -$24.5M 2.04% 17
2018
Q2
$1.07B Sell
13,799,574
-604,857
-4% -$45.4M 1.72% 23
2018
Q1
$995M Sell
14,404,431
-2,691,215
-16% -$205M 1.58% 28
2017
Q4
$1.28B Sell
17,095,646
-1,608,443
-9% -$103M 1.9% 23
2017
Q3
$1.18B Sell
18,704,089
-1,603,152
-8% -$99.6M 1.78% 27
2017
Q2
$1.3B Buy
20,307,241
+2,694,407
+15% +$169M 1.97% 17
2017
Q1
$1.16B Buy
17,612,834
+704,218
+4% +$48.5M 1.75% 22
2016
Q4
$1.16B Sell
16,908,616
-498,700
-3% -$35.7M 1.74% 25
2016
Q3
$1.23B Buy
17,407,316
+2,760,945
+19% +$206M 1.87% 21
2016
Q2
$1.11B Buy
14,646,371
+4,874,043
+50% +$358M 1.69% 28
2016
Q1
$671M Buy
+9,772,328
New +$703M 1.03% 37

Other funds holding ESRX

Barrow, Hanley, Mewhinney & Strauss's ESRX Position: Q4 2018 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 13,511,900 shares — an estimated $1.28B sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in ESRX in Q1 2016 and held it in 11 quarters. The position peaked at $1.3B in Q2 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 13,511,900 Express Scripts Holding Company shares in Q4 2018, an estimated $1.28B.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Express Scripts Holding Company in Q1 2016 and held it in 11 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Express Scripts Holding Company position peaked at $1.3B in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2018, filed 13 Feb 2019.